The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.

Full Abstract

Drug induced cognitive change is generally investigated using small sample sizes. In terms of null hypothesis significance testing (NHST) this can render a meaningful change non-significant, as a result of insufficient power in the statistical model. NHST leads to 'all or none' thinking, where a non-significant result is interpreted as an absence of change. An effect size calculation indicates the magnitude of change which has occurred post-intervention, and therefore whether a significant result is meaningful. We used a scopolamine challenge to demonstrate the usefulness of effect sizes. The aim of the study was to determine how effect sizes could describe the cognitive changes that occur following administration of subcutaneous scopolamine (s.c. scopolamine). Twenty four healthy young males (M = 32.6, sd = 4.5 years) were administered placebo and 0.2 mg, 0.4 mg & 0.6 mg of s.c. scopolamine using a 4-way crossover design. Memory, learning, psychomotor function, attention and executive function were assessed. Scopolamine significantly impaired performance on all tasks in a dose and time related manner. These results demonstrate the functionality of change scores to draw comparisons between different times and doses. This methodology overcomes the limitations of comparisons between studies using different tasks, doses and time at which cognitive functions are measured. (c) 2008 John Wiley & Sons, Ltd.

Author information

Author/s: Fredrickson, Amy (A); Snyder, Peter J (PJ); Cromer, Jennifer (J); Thomas, Elizabeth (E); Lewis, Matthew (M); Maruff, Paul (P);

Affiliation: CogState Ltd, Melbourne, Australia.

Journal and publication information

Publication Type: Journal Article; Randomized Controlled Trial

Journal: Human psychopharmacology (Hum Psychopharmacol), published in England. (Language: eng)

Reference: 2008-Jul; vol 23 (issue 5) : pp 425-36

Dates: Created 2008/06/25; Completed 2008/07/31;

PMID: 18421801, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.